Related references
Note: Only part of the references are listed.Levetiracetam as an Adjunctive Treatment for Mania: A Double-Blind, Randomized, Placebo-Controlled Trial
Amir Keshavarzi et al.
NEUROPSYCHOBIOLOGY (2022)
Where to prospectively register a systematic review
Dawid Pieper et al.
SYSTEMATIC REVIEWS (2022)
Levetiracetam Mechanisms of Action: From Molecules to Systems
Itzel Jatziri Contreras-Garcia et al.
PHARMACEUTICALS (2022)
Can levetiracetam improve clinical symptoms in schizophrenic patients? A randomized placebo-controlled clinical trial
Fatemeh Behdani et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2022)
Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
I-Chen Tsai et al.
FRONTIERS IN PHARMACOLOGY (2022)
The challenge of neuropsychological assessment of visual/visuo-spatial memory: A critical, historical review, and lessons for the present and future
Unai Diaz-Orueta et al.
FRONTIERS IN PSYCHOLOGY (2022)
HOPE4MCI trial: First trial targeting reduction of hippocampal overactivity to treat mild cognitive impairment due to Alzheimer’s disease with AGB101
Sharon Rosenzweig‐Lipson et al.
Alzheimers & Dementia (2021)
Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity A Randomized Clinical Trial
Keith Vossel et al.
JAMA NEUROLOGY (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Amyloid-β: a potential link between epilepsy and cognitive decline
Michele Romoli et al.
NATURE REVIEWS NEUROLOGY (2021)
An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study
Arjune Sen et al.
TRIALS (2021)
Treatment of epilepsy for people with Alzheimer's disease
Jia Liu et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Domains of cognition and their assessment
Philip D. Harvey
DIALOGUES IN CLINICAL NEUROSCIENCE (2019)
The cingulum bundle: Anatomy, function, and dysfunction
Emma J. Bubb et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Tolerability, efficacy and retention rate of Brivaracetam in patients previously treated with Levetiracetam: A monocenter retrospective outcome analysis
Martin Hirsch et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2018)
A randomized, double-blind, placebo-controlled crossover study of the effects of levetiracetam on cognition, mood, and balance in healthy older adults
Mike R. Schoenberg et al.
EPILEPSIA (2017)
Levetiracetam Alters Oscillatory Connectivity in Alzheimer's Disease
Christian S. Musaeus et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes
Sara Sanz-Blasco et al.
NEUROREPORT (2016)
Zonisamide, Topiramate, and Levetiracetam Efficacy and Neuropsychological Effects in Alcohol Use Disorders
Clifford M. Knapp et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance
Arnold Bakker et al.
NEUROIMAGE-CLINICAL (2015)
The Influence of Levetiracetam in Cognitive Performance in Healthy Individuals: Neuropsychological, Behavioral and Electrophysiological Approach
Julio Cesar Magalhaes et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2015)
Effects of heavy drinking on executive cognitive functioning in a community sample
Rebecca J. Houston et al.
ADDICTIVE BEHAVIORS (2014)
Normal Cognitive Aging
Caroline N. Harada et al.
CLINICS IN GERIATRIC MEDICINE (2013)
Subclinical epileptiform activity in children with electrical status epilepticus during sleep: Effects on cognition and behavior before and after treatment with levetiracetam
Helge Bjornaes et al.
EPILEPSY & BEHAVIOR (2013)
The effect of levetiracetam on focal nocturnal epileptiform activity during sleep - A placebo-controlled double-blind cross-over study
Pal Gunnar Larsson et al.
EPILEPSY & BEHAVIOR (2012)
Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment
Arnold Bakker et al.
NEURON (2012)
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model
Pascal E. Sanchez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam
Kimford J. Meador et al.
EPILEPSIA (2011)
Evaluation of the subjective and reinforcing effects of diphenhydramine, levetiracetam, and valproic acid
Douglas E. Feltner et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Individual differences in spatial pattern separation performance associated with healthy aging in humans
Shauna M. Stark et al.
LEARNING & MEMORY (2010)
High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic Mild Cognitive Impairment
Michael A. Yassa et al.
NEUROIMAGE (2010)
Treatment Strategies Targeting Excess Hippocampal Activity Benefit Aged Rats with Cognitive Impairment
Ming Teng Koh et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: A randomized, double-blind, placebo-controlled, noninferiority trial
Paul M. Levisohn et al.
EPILEPSIA (2009)
Increased EEG Current-Source Density in the High Beta Frequency Band Induced by Levetiracetam Adjunctive Therapy in Refractory Partial Epilepsy
Sung-Pa Park et al.
JOURNAL OF CLINICAL NEUROLOGY (2009)
Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies
Philip N. Patsalos et al.
EPILEPSIA (2008)
Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures
Bo Zhou et al.
EPILEPSY & BEHAVIOR (2008)
Central nervous system adverse effects of new antiepileptic drugs - A meta-analysis of placebo-controlled studies
G. Zaccara et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2008)
Impact of levetiracetam on mood and cognition during prednisone therapy
E. Sherwood Brown et al.
EUROPEAN PSYCHIATRY (2007)
Current concepts - Memory dysfunction
AE Budson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
BA Lynch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers
O Mecarelli et al.
ANNALS OF PHARMACOTHERAPY (2004)
Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases
V Dinkelacker et al.
EPILEPSY & BEHAVIOR (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
EEG synchronization in mild cognitive impairment and Alzheimer's disease
CJ Stam et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
Effect of lamotrigine on mood and cognition in patients receiving chronic exogenous corticosteroids
ES Brown et al.
PSYCHOSOMATICS (2003)
A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials
JA Cramer et al.
EPILEPSY & BEHAVIOR (2003)
Routes to remembering: the brains behind superior memory
EA Maguire et al.
NATURE NEUROSCIENCE (2003)
Share Paper
